Erratum for Cercamondi et al. Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women. Am J Clin Nutr 2010;92:1385–92. (The American Journal of Clinical Nutrition (2010) 92(6) (1385–1392), (S0002916523021445), (10.3945/ajcn.2010.30051));Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: A double stable-isotope study in young Beninese women

American Journal of Clinical Nutrition

Volumn 92, Issue 6, 2010, Pages 1385-1392

  Cercamondi, Colin I ^a   Egli, Ines M ^a   Ahouandjinou, Ella ^b   Dossa, Romain ^b   Zeder, Christophe ^a   Salami, Lamidhi ^c   Tjalsma, Harold ^c   Wiegerinck, Erwin ^d   Tanno, Toshihiko ^e   Hurrell, Richard F ^a   Hounhouigan, Joseph ^b   Zimmermann, Michael B ^a,f  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

^c Médecin Coordonnateur de la Zone Sanitaire Atacora Donga   (Benin)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRIC CITRATE FE 58; FERRIC SODIUM EDETATE FE 57; FERRITIN; GROWTH DIFFERENTIATION FACTOR 15; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; IRON; IRON DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BENIN; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON METABOLISM; IRON THERAPY; ISOTOPE LABELING; MALARIA; PARASITEMIA; PLASMODIUM FALCIPARUM; SORGHUM;

PLASMODIUM FALCIPARUM;

EID: 78651272558     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.107805     Document Type: Erratum

References (71)

1. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007; 370:511-20.
2. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to consumption of a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan children. Am J Clin Nutr 2005;81:115-21.
3. Newton CRJC, Warn PA, Winstanley PA, et al. Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 1997;2:165-78.
4. Menendez C, Schellenberg D, Quinto L, et al. The effects of short-term iron supplementation on iron status in infants in malaria-endemic areas. Am J Trop Med Hyg 2004;71:434-40.
5. WHO, FAO. Guidelines on food fortification with micronutrients. Geneva, Switzerland: WHO/FAO, 2006.
6. Rohner F, Zimmermann MB, Amon RJ, et al. In a randomized controlled trial of iron fortification, anthelmintic treatment and intermittent preventive treatment of malaria for anemia control in ivorian children, only anthelmintic treatment shows modest benefit. J Nutr 2010;140:635-41.
7. Wegmuller R, Camara F, Zimmermann MB, Adou P, Hurrell RF. Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. J Nutr 2006;136:1814-20.
8. Andang'o PEA, Osendarp SJM, Ayah R, et al. Efficacy of iron-fortified whole maize flour on iron status of schoolchildren in Kenya: a randomised controlled trial. Lancet 2007;369:1799-806.
9. WHO. The World Health Report 1999: making a difference. Geneva, Switzerland: World Health Organization, 1999.
10. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998;18:555-9.
11. Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ. Malarial anemia: of mice and men. Blood 2007;110:18-28.
12. Wenisch C, Linnau KF, Looaresuwan S, Rumpold H. Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J Infect Dis 1999;179:747-50.
13. Lyke KE, Burges R, Cissoko Y, et al. Serum levels of the proin- flammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004;72:5630-7.
14. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009;1790:682-93.
15. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
16. Lee P, Peng HF, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005;102:1906-10.
17. Doherty CP, Cox SE, Fulford AJ, et al. Iron incorporation and post-malaria anaemia. PLoS ONE 2008;3:e2133.
18. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007;13:1096-101.
19. de Mast Q, Syafruddin D, Keijmel S, et al. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 2010;95:1068-74.
20. Eke RA, Chigbu LN. W. N. High prevalence of asymptomatic plasmodium infection in a suburb of Aba Town, Nigeria. Ann Afr Med 2006;5:42-5.
21. Agan TU, Ekabua JE, Iklaki CU, Oyo-Ita A, Ibanga I. Prevalence of asymptomatic malaria parasitaemia. Asian Pac J Trop Med 2010;3:51-4.
22. Onyenekwe CC, Meludu SC, Dioka CE, Salimonu LS. Prevalence of asymptomatic malaria parasitaemia amongst pregnant women. Indian J Malariol 2002;39:60-5.
23. Imrie H, Fowkes FJI, Michon P, Tavul L, Reeder JC, Day KP. Low prevalence of an acute phase response in asymptomatic children from a malaria-endemic area of Papua New Guinea. Am J Trop Med Hyg 2007;76:280-4.
24. Carneiro IA, Smith T, Lusingu JPA, Malima R, Utzinger J, Drakeley CJ. Modeling the relationship between the population prevalence of Plasmodium falciparum malaria and anemia. Am J Trop Med Hyg 2006;75: 82-9.
25. MARA/ARMA Collaboration. 2001. Malaria seasonality model. Available from: www.mara.org.za. (cited May 2009).
26. MARA/ARMA Collaboration. 2002. Malaria prevalence model. Available from: www.mara.org.za. (cited May 2009).
27. Kastenmayer P, Davidsson L, Galan P, Cherouvrier F, Hercberg S, Hurrell RF. A double stable-isotope technique for measuring iron-absorption in infants. Br J Nutr 1994;71:411-24.
28. Walczyk T, Davidsson L, Zavaleta N, Hurrell RF. Stable isotope labels as a tool to determine the iron absorption by Peruvian school children from a breakfast meal. Fresenius J Anal Chem 1997;359:445-9.
29. Zimmermann MB, Fucharoen S, Winichagoon P, et al. Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Am J Clin Nutr 2008;88:1026-31.
30. Roe MA, Heath ALM, Oyston SL, et al. Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 2005;81:814-21.
31. Makower RU. Extraction and determination of phytic acid in beans (Phaseolus-vulgaris). Cereal Chem 1970;47:288-96.
32. Van Veldhoven PP, Mannaerts GP. Inorganic and organic phosphate measurements in the nanomolar range. Anal Biochem 1987;161:45-8.
33. Singleton VL, Rossi JA, Jr. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965;16:144-58.
34. Davidsson L, Ziegler E, Zeder C, Walczyk T, Hurrell R. Sodium iron EDTA [NaFe(III)EDTA] as a food fortificant: erythrocyte incorporation of iron and apparent absorption of zinc, copper, calcium, and magnesium from a complementary food based on wheat and soy in healthy infants. Am J Clin Nutr 2005;81:104-9.
35. Dainty JR, Roe MA, Teucher B, Eagles J, Fairweather-Tait SJ. Quantification of unlabelled non-haem iron absorption in human subjects: a pilot study. Br J Nutr 2003;90:503-6.
36. WHO/UNICEF/UNU, ed. Iron deficiency anemia assessment, prevention and control. Geneva, Switzerland: World Health Organization, 2001.
37. Zimmermann MB. Methods to assess iron and iodine status. Br J Nutr 2008;99:S2-9.
38. Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE 2008;3:e2706.
39. Kroot JJC, Hendriks JCM, Laarakkers CMM, et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 2009; 389:124-9.
40. Geigy Scientific Tables. Hematology and human genetics. Basel, Switzerland: Ciba-Geigy Ltd, 1979.
41. Ballot DE, Macphail AP, Bothwell TH, Gillooly M, Mayet FG. Forti- fication of curry powder with NaFe(111)EDTA in an iron-deficient population - report of a controlled iron-fortification trial. Am J Clin Nutr 1989;49:162-9.
42. Garby L, Areekul S. Iron supplementation in Thai fish-sauce. Ann Trop Med Parasitol 1974;68:467-76.
43. Davidsson L, Dimitriou T, Boy E, Walczyk T, Hurrell RF. Iron bioavailability from iron-fortified Guatemalan meals based on corn tortillas and black bean paste. Am J Clin Nutr 2002;75:535-9.
44. Macphail AP, Bothwell TH, Torrance JD, et al. Factors affecting the absorption of iron from Fe(III)EDTA. Br J Nutr 1981;45:215-27.
45. Layrisse M, Martineztorres C. Fe(III)-EDTA complex as iron fortification. Am J Clin Nutr 1977;30:1166-74.
46. Derman DP, Bothwell TH, Torrance JD, et al. Iron-Absorption from Ferritin and Ferric Hydroxide. Scand J Haematol 1982;29:18-24.
47. Derman DP, Bothwell TH, Torrance JD, et al. Iron-absorption from maize (Zea mays) and sorghum (Sorghum vulgare) beer. Br J Nutr 1980; 43:271-9.
48. de Mast Q, Nadjm B, Reyburn H, et al. Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 2009;199:253-62.
49. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anemia in cerebral and uncomplicated falciparum-malaria-a role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986; 58:305-23.
50. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr 2009;90: 1280-7.
51. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6.
52. Wrighting DM, Andrews NC. Interleukin induces hepcidin expression through STAT3. Blood 2006;108:3204-9.
53. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006; 108:3730-5.
54. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007;117:1926-32.
55. Howard CT, McKakpo US, Quakyi IA, et al. Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg 2007;77: 623-6.
56. Hviid L. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop 2005;95:270-5.
57. de Mast Q, van Dongen-Lases EC, Swinkels DW, et al. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 2009;145:657-64.
58. Wang CQ, Udupa KB, Lipschitz DA. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor-cell development. J Cell Physiol 1995;162:134-8.
59. Dallalio G, Law E, Means RT. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006; 107:2702-4.
60. Spivak JL. The blood in systemic disorders. Lancet 2000;355:1707-12.
61. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000;13:277-99.
62. Nweneka CV, Doherty CP, Cox S, Prentice A. Iron delocalisation in the pathogenesis of malarial anaemia. Trans R Soc Trop Med Hyg 2009; 104:175-84.
63. Mahmoudi N, Ciceron L, Franetich JF, et al. In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother 2003;47:2636-9.
64. Goodman CD, Su V, McFadden GI. The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 2007; 152:181-91.
65. Watt G, Shanks GD, Edstein MD, Pavanand K, Webster HK, Wechgritaya S. Ciprofloxacin treatment of drug-resistant falciparum malaria. J Infect Dis 1991;164:602-4.
66. Stromberg A, Bjorkman A. Ciprofloxacin does not achieve radical cure of Plasmodium falciparum infection in Sierra Leone. Trans R Soc Trop Med Hyg 1992;86:373-373.
67. Takala S, Branch O, Escalante AA, Kariuki S, Wootton J, Lal AA. Evidence for intragenic recombination in Plasmodium falciparum: identification of a novel allele family in block 2 of merozoite surface protein-1: Asembo Bay Area Cohort Project XIV. Mol Biochem Parasitol 2002;125:163-71.
68. Patarroyo ME, Amador R, Clavijo P, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 1988;332:158-61.
69. Bottius E, Guanzirolli A, Trape JF, Rogier C, Konate L, Druilhe P. Malaria: even more chronic in nature than previously thought; Evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Trans R Soc Trop Med Hyg 1996;90:15-9.
70. Greenwood B. Review: intermittent preventive treatment - a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 2006;11:983-91.
71. Odhiambo FO, Hamel MJ, Williamson J, et al. Intermittent preventive treatment in infants for the prevention of malaria in rural western Kenya: a randomized, double-blind placebo-controlled trial. PLoS ONE 2010;5: e10016.